Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases.
The effect of weight loss with anorectic medications on sleep apnea, non-insulin-dependent diabetes, and steatohepatitis is illustrated in three cases from practice in a clinical nutrition setting. Prevention of obesity, a chronic disorder, is preferable, but when obesity becomes a major obstacle in the care of patients with respiratory, cardiovascular, and metabolic disorders and osteoarthritis, an intense course of weight reduction using anorectic medications under medical and dietetic guidance is essential for patients' survival and reduction of medical cost.
DeMeo
M T
MT
Clinical Nutrition Unit, Loyola University Medical Center, Maywood, IL 60153, USA.
Mobarhan
S
S
Mikolaitis
S
S
Kazi
N
N
D000328:Adult; D000368:Aged; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000628:therapy; D004038:Diet, Reducing; D005234:Fatty Liver / Q000209:etiology / Q000628:therapy; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects / Q000627:therapeutic use; D006505:Hepatitis / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications* / Q000178:diet therapy / Q000628:therapy*; D010645:Phentermine / Q000009:adverse effects / Q000627:therapeutic use; D012891:Sleep Apnea Syndromes / Q000209:etiology / Q000628:therapy
D001067:Appetite Depressants; D005277:Fenfluramine; D010645:Phentermine